Literature DB >> 18824727

Chromosome 3 intratumor heterogeneity in uveal melanoma.

Hanneke W Mensink1, Jolanda Vaarwater, Emine Kiliç, Nicole C Naus, Neeltje Mooy, Gre Luyten, Hennie T Brüggenwirth, Dion Paridaens, Annelies de Klein.   

Abstract

PURPOSE: To investigate the presence of focal or diffuse heterogeneity of monosomy 3 in uveal melanoma, by using fluorescence in situ hybridization (FISH).
METHODS: Direct interphase FISH in a series of 151 uveal melanomas revealed 82 tumors with loss of chromosome 3. Tumors with monosomy 3 were suspected to be heterogeneous if there were low percentages of monosomy 3, triploid clones, inconsistencies between FISH on centromere 3 and the long arm of chromosome 3, or discrepancies between fine-needle-aspiration biopsies (FNABs) and the main tumor. These tumors (n=16), all choroidal melanomas, were selected and analyzed for intratumor heterogeneity by using FISH on paraffin-embedded tissue sections.
RESULTS: Different sections of each tumor were evaluated with FISH: 6 tumors showed monosomy 3 in the same percentage throughout the tumor, and 10 showed multiple clones with different percentages of monosomy 3. However, these tumors did not show focal heterogeneity with respect to chromosome 3 status, and differences in monosomy 3 distribution between the base and apex of the tumor could not be identified.
CONCLUSIONS: Although a small number of uveal melanomas show heterogeneity for chromosome 3, it does not affect survival. In the presence of triploid clones, the loss of chromosome 3 is more difficult to interpret. In general, tumor biopsies in uveal melanoma provide an accurate prediction of the patient's prognosis.

Entities:  

Mesh:

Year:  2008        PMID: 18824727     DOI: 10.1167/iovs.08-2279

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  24 in total

1.  Frequency, molecular pathology and potential clinical significance of partial chromosome 3 aberrations in uveal melanoma.

Authors:  Mohamed H Abdel-Rahman; Benjamin N Christopher; Mohammed F Faramawi; Khaled Said-Ahmed; Carol Cole; Andrew McFaddin; Abhik Ray-Chaudhury; Nyla Heerema; Frederick H Davidorf
Journal:  Mod Pathol       Date:  2011-04-15       Impact factor: 7.842

2.  Molecular genetic testing of uveal melanoma from routinely processed and stained cytology specimens.

Authors:  Benjamin N Christopher; Colleen M Cebulla; Paul E Wakely; Frederick H Davidorf; Mohamed H Abdel-Rahman
Journal:  Exp Eye Res       Date:  2011-09-17       Impact factor: 3.467

3.  Combined mutation and copy-number variation detection by targeted next-generation sequencing in uveal melanoma.

Authors:  Kyra N Smit; Natasha M van Poppelen; Jolanda Vaarwater; Robert Verdijk; Ronald van Marion; Helen Kalirai; Sarah E Coupland; Sophie Thornton; Neil Farquhar; Hendrikus-Jan Dubbink; Dion Paridaens; Annelies de Klein; Emine Kiliç
Journal:  Mod Pathol       Date:  2018-01-12       Impact factor: 7.842

4.  Frequency and implications of discordant gene expression profile class in posterior uveal melanomas sampled by fine needle aspiration biopsy.

Authors:  James J Augsburger; Zélia M Corrêa; Bret D Augsburger
Journal:  Am J Ophthalmol       Date:  2014-11-05       Impact factor: 5.258

5.  Chromosome 3 status in uveal melanoma: a comparison of fluorescence in situ hybridization and single-nucleotide polymorphism array.

Authors:  Arun D Singh; Mary E Aronow; Yang Sun; Gurkan Bebek; Yogen Saunthararajah; Lynn R Schoenfield; Charles V Biscotti; Raymond R Tubbs; Pierre L Triozzi; Charis Eng
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-05       Impact factor: 4.799

6.  An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma.

Authors:  Michael D Onken; Lori A Worley; Meghan D Tuscan; J William Harbour
Journal:  J Mol Diagn       Date:  2010-04-22       Impact factor: 5.568

Review 7.  Molecular pathology of uveal melanoma.

Authors:  S E Coupland; S L Lake; M Zeschnigk; B E Damato
Journal:  Eye (Lond)       Date:  2012-12-07       Impact factor: 3.775

Review 8.  Uveal melanoma: From diagnosis to treatment and the science in between.

Authors:  Chandrani Chattopadhyay; Dae Won Kim; Dan S Gombos; Junna Oba; Yong Qin; Michelle D Williams; Bita Esmaeli; Elizabeth A Grimm; Jennifer A Wargo; Scott E Woodman; Sapna P Patel
Journal:  Cancer       Date:  2016-03-15       Impact factor: 6.860

9.  Intratumoral Heterogeneity in Uveal Melanoma.

Authors:  Cristina Fonseca; Rita Pinto-Proença; Sabrina Bergeron; Luís Miguel Pires; Júlia Fernandes; Isabel Marques Carreira; Miguel N Burnier; Rui Proença
Journal:  Ocul Oncol Pathol       Date:  2020-08-25

10.  The DecisionDx-UM Gene Expression Profile Test Provides Risk Stratification and Individualized Patient Care in Uveal Melanoma.

Authors:  J William Harbour; Royce Chen
Journal:  PLoS Curr       Date:  2013-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.